Cat. No. | Product name | CAS No. |
DC8801 |
Cinacalcet (AMG-073)
Featured
Cinacalcet(AMG-073) is an orally active, second-generation calcimimetic compound; AMG 073 represents a new class of compounds for the treatment of hyperparathyroidism. |
226256-56-0 |
DC12369 |
Cinaciguat (hydrochloride)
Featured
Cinaciguat is an activator of sGC that binds to a regulatory site, resulting in activation in an NO-independent manner (Kd = 3.2 nM). |
646995-35-9 |
DC20093 |
Cinchonine ((8R,9S)-Cinchonine; LA40221)
Featured
Cinchonine is a natural compound present in Cinchona bark. Cinchonine activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells. |
118-10-5 |
DC9896 |
Cinnarizine
Featured
Cinnarizine is a medication derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker. |
298-57-7 |
DCH-062 |
Cinobufotalin
Featured
Cinobufotalin is a steroid glycoside originally isolated from the Asiatic toad (B. gargarizans) and has diverse biological activities. |
1108-68-5 |
DC22295 |
Cintirorgon sodium
Featured
Cintirorgon (LYC-55716) is novel oral RAR-related orphan receptor γ (RORγ) agonist. |
2055538-47-9 |
DC22329 |
Cintirorgon
Featured
Cintirorgon (LYC-55716) is novel oral RAR-related orphan receptor γ (RORγ) agonist. |
2055536-64-4 |
DCAPI1372 |
Ciprofloxacin (Cipro)
Featured
Ciprofloxacin (Bay-09867) is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity. |
85721-33-1 |
DC2062 |
Ciproxifan (FUB-359)
Featured
Ciproxifan is an antagonists of H3-type histamine receptors. |
184025-18-1 |
DC9466 |
Ciproxifan (maleate)
Featured
Ciproxifan maleate(FUB-359 maleate) is a highly potent and selective histamin H3-receptor antagonist with IC50 of 9.2 nM, with low apparent affinity at other receptor subtypes. |
184025-19-2 |
DC8156 |
CIQ
Featured
CIQ is a positive allosteric modulator selective for NR2C/D containing NMDA receptors (EC50 = 2.7 and 2.8 µM for NR2C and NR2D, respectively). |
486427-17-2 |
DC8187 |
Ciraparantag(PER977)
Featured
Ciraparantag(PER977) is an intravenously administered anticoagulant Reversal Agent. |
1438492-26-2 |
DCAPI1600 |
Cisapride
Featured
Cisapride is a SR-4 agonist also known as Enteropride |
81098-60-4 |
DC9517 |
Cisatracurium (besylate)
Featured
Cisatracurium Besylate is a nondepolarizing neuromuscular blocking agent, antagonizing the action of acetylcholine by inhibiting neuromuscular transmission. |
96946-42-8 |
DC2099 |
cis-Diaminedichloroplatinum
Featured
Cisplatin is an inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. |
15663-27-1 |
DC12668 |
Citarinostat(ACY-241)
Featured
Citarinostat(ACY-241) is a potent, selective and orally available histone deacetylase (HDAC) inhibitor, with potential antineoplastic activity. |
1316215-12-9 |
DC20906 |
CJ-13610
Featured
CJ-13610 is a potent 5-Lipoxygenase (5-LO) inhibitor that suppresses 5-LO product formation with IC50 of 70 nM. |
179420-17-8 |
DC20907 |
CK 666
Featured
CK 666 (CK 0944666) is a small molecule Arp2/3 complex inhibitor with IC50 of 4 uM, inhibits actin polymerization with either BtArp2/3 complex (IC50=17 uM) or SpArp2/3 complex (IC50=5 uM). |
442633-00-3 |
DC11673 |
CK-2127107
Featured
CK-2127107(CK-107, Reldesemtiv) is a novel orally active fast skeletal troponin activator, selectively activates fast skeletal myofibrils with EC50 of 3.4 uM. |
1345410-31-2 |
DC7386 |
CK-636
Featured
CK-636(CK-0944636) is a small molecule inhibitor of Arp2/3 complex; Inhibitor of actin polymerization; Cell permeable inhibitor of human (IC50=4μM), fission yeast (IC50=24μM) and bovine (IC50=32μM) Arp2/3 complex between Arp2 and Arp3. |
442632-72-6 |
DC11475 |
CK-869
Featured
CK-869 is an inhibitor of human and bovine actin-related protein 2/3 (Arp2/3) complex. |
388592-44-7 |
DC12595 |
CL27c
Featured
CL27c is a cell-permeable, inhaled lipophilic ester prodrug of CL27e, which is a potent, selective pan-class I PI3K inhibitor, CL27c is inactive in PI3K enzymatic assay, once inside the cytoplasm, CL27c is metabolized by unspecific esterases into CL27e. |
1380227-11-1 |